What is Capricor Therapeutics's PP&E (net)?

Capricor Therapeutics (CAPR) reported PP&E (net) of $28.5M in Q1 2026.

How has Capricor Therapeutics's PP&E (net) changed year-over-year?

Capricor Therapeutics's PP&E (net) increased by 364.7% year-over-year, from $6.13M to $28.5M.

What is the long-term trend for Capricor Therapeutics's PP&E (net)?

Over 5 years (2020 to 2025), Capricor Therapeutics's PP&E (net) has grown at a 84.7% compound annual growth rate (CAGR), from $850.85K to $18.31M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Capricor Therapeutics CAPR PP&E (Net)

PP&E (Net) at other companies

PfizerPFE

$19.4B+5.8%

Sarepta Therapeutics, Inc.SRPT

$336.24M-6.8%

PTC TherapeuticsPTCT

$52.74M-11.3%

Celldex TherapeuticsCLDX

$7.4M+60.7%

VericelVCEL

$107.11M-1.1%

Dyne Therapeutics, Inc.DYN

$23.68M+312%

Other financials

Income statement

See full

Revenue--100%

Operating income-$36.8M-47.2%

Net income-$33.9M-39.2%

EPS (diluted)-$0.59-11.3%

Balance sheet

See full

Cash & equivalents$105.4M+266%

Total debt$14.8M+1,083%

Total equity$278.7M+118%

Total assets$326.3M+112%

Cash flow

See full

Operating cash flow-$29.3M-355%

CapEx$5.1M+472%

Free cash flow-$34.4M-369%

Valuation

See full

Market cap$1.71B+303%

Enterprise value$1.62B+308%

Profitability

See full

Operating margin-778.8%-1,038pp

Net margin-736.6%-981pp

FCF margin-563.9%-954pp

Returns & leverage

See full

Return on equity-56.4%-11.3pp

Debt / equity0.1×0.0×

Current ratio8.4×+1.9×

Where this comes from

Reported directly by Capricor Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Capricor Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Capricor Therapeutics's pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Capricor Therapeutics's PP&E (net)?: Capricor Therapeutics (CAPR) reported PP&E (net) of $28.5M in Q1 2026.
How has Capricor Therapeutics's PP&E (net) changed year-over-year?: Capricor Therapeutics's PP&E (net) increased by 364.7% year-over-year, from $6.13M to $28.5M.
What is the long-term trend for Capricor Therapeutics's PP&E (net)?: Over 5 years (2020 to 2025), Capricor Therapeutics's PP&E (net) has grown at a 84.7% compound annual growth rate (CAGR), from $850.85K to $18.31M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.